RAC 3.08% $1.68 race oncology ltd

Speculative M&A Transaction Analysis, page-729

  1. 2,328 Posts.
    lightbulb Created with Sketch. 345
    Standard operating procedure: minnow takes the risk up to/including trials, toxicology, formulation etc, major company pays for the right to progress to market and sales. I'd imagine they will pay much more later on the development track ( less risk ) , rather than pay less at the early developmental stages (most risk).
    Major pharmaceutical companies have their finger on every potential new/ongoing drug development ( & no they wouldn't be relying on HC threads for their market intelligence ).
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.68
Change
0.050(3.08%)
Mkt cap ! $285.4M
Open High Low Value Volume
$1.65 $1.75 $1.64 $210.4K 125.8K

Buyers (Bids)

No. Vol. Price($)
1 5000 $1.65
 

Sellers (Offers)

Price($) Vol. No.
$1.68 595 1
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.